HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xinying Li Selected Research

6- (beta- pyridyl)- 3- hydroxy- pyrazol(3,4b)pyridine

11/2018Prediction of permanent hypoparathyroidism by parathyroid hormone and serum calcium 24 h after thyroidectomy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xinying Li Research Topics

Disease

55Neoplasms (Cancer)
07/2022 - 09/2005
14Thyroid Neoplasms (Thyroid Cancer)
03/2022 - 11/2012
14Neoplasm Metastasis (Metastasis)
01/2022 - 09/2005
11Papillary Thyroid Cancer
03/2022 - 02/2013
9Carcinogenesis
07/2022 - 01/2011
9Hepatocellular Carcinoma (Hepatoma)
01/2022 - 01/2012
6Colitis
03/2022 - 03/2011
5Wounds and Injuries (Trauma)
06/2022 - 02/2016
5Necrosis
06/2022 - 12/2016
5Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
03/2022 - 03/2011
5Carcinoma (Carcinomatosis)
03/2022 - 09/2005
5Inflammation (Inflammations)
04/2021 - 09/2013
4Infections
06/2022 - 01/2020
4Sepsis (Septicemia)
01/2021 - 10/2010
4Ovarian Neoplasms (Ovarian Cancer)
11/2017 - 05/2014
3Breast Neoplasms (Breast Cancer)
01/2022 - 01/2016
3Multiple Myeloma
01/2022 - 08/2019
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
12/2021 - 01/2006
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
08/2021 - 06/2016
3Hypoparathyroidism
04/2021 - 11/2018
2Ulcer
06/2022 - 06/2020
2Diabetic Foot
06/2022 - 06/2020
2Hypocalcemia
01/2022 - 01/2019
2Poisoning
01/2022 - 01/2021
2Liver Neoplasms (Liver Cancer)
01/2019 - 07/2018
2Follicular Adenocarcinoma
02/2013 - 10/2012
2Weight Loss (Weight Reduction)
01/2012 - 03/2011
1Thyroid Diseases (Thyroid Disease)
11/2022
1Obesity
08/2022
1Neuroinflammatory Diseases
08/2022
1Cardiovascular Diseases (Cardiovascular Disease)
07/2022
1Extramammary Paget Disease (Paget Disease, Extramammary)
06/2022
1Botulism
01/2022
1Ebola Hemorrhagic Fever
01/2022

Drug/Important Bio-Agent (IBA)

13Proteins (Proteins, Gene)FDA Link
01/2022 - 07/2011
10MicroRNAs (MicroRNA)IBA
01/2022 - 05/2012
8Long Noncoding RNAIBA
01/2021 - 02/2013
6Biomarkers (Surrogate Marker)IBA
07/2022 - 10/2014
6Circular RNAIBA
07/2022 - 07/2018
6CytokinesIBA
05/2022 - 10/2010
6Monoclonal AntibodiesIBA
11/2021 - 07/2012
51-phenyl-3,3-dimethyltriazene (PDT)IBA
06/2022 - 09/2019
5Biological ProductsIBA
03/2022 - 04/2013
5Messenger RNA (mRNA)IBA
02/2020 - 07/2011
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2020 - 01/2012
5LigandsIBA
06/2019 - 12/2012
4Pharmaceutical PreparationsIBA
03/2022 - 02/2013
4Untranslated RNA (Noncoding RNA)IBA
01/2020 - 11/2012
3Dextran SulfateIBA
03/2022 - 01/2012
3CarbonIBA
12/2021 - 03/2019
3Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
11/2021 - 06/2019
3Trastuzumab (Herceptin)FDA Link
11/2017 - 11/2014
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2017 - 02/2014
2Anti-Bacterial Agents (Antibiotics)IBA
06/2022 - 12/2021
2AcidsIBA
06/2022 - 06/2020
2Therapeutic UsesIBA
03/2022 - 01/2020
2RNA (Ribonucleic Acid)IBA
01/2022 - 01/2020
2Antisense RNA (Anti-Sense RNA)IBA
01/2022 - 01/2020
2Tyrosine Kinase InhibitorsIBA
11/2021 - 08/2021
2ErbB Receptors (EGF Receptor)IBA
08/2021 - 01/2016
2CalciumIBA
04/2021 - 11/2018
2EpitopesIBA
01/2021 - 01/2013
2AntibodiesIBA
01/2021 - 03/2011
2LipopolysaccharidesIBA
01/2021 - 01/2020
2Indicators and Reagents (Reagents)IBA
11/2020 - 01/2020
2CateninsIBA
01/2020 - 04/2018
2Peptides (Polypeptides)IBA
12/2019 - 09/2013
2Competitive Endogenous RNAIBA
07/2018 - 04/2013
2MucinsIBA
01/2018 - 03/2013
2Receptors for Activated C KinaseIBA
12/2016 - 01/2013
2Cadherins (E-Cadherin)IBA
10/2014 - 11/2013
2Carrier Proteins (Binding Protein)IBA
10/2014 - 09/2013
2Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA
09/2013 - 01/2012
2Type I Tumor Necrosis Factor ReceptorsIBA
09/2013 - 01/2012
2Protein Kinases (Protein Kinase)IBA
09/2013 - 01/2011
2Mucin-3IBA
03/2013 - 12/2012
2HMGB1 Protein (HMG1)IBA
04/2012 - 01/2012
2Complement C5a (Complement 5a)IBA
07/2011 - 10/2010
2Anaphylatoxin C5a ReceptorIBA
07/2011 - 03/2011
2Complement System Proteins (Complement)IBA
03/2011 - 10/2010
1Palmitic Acid (Hexadecanoic Acid)IBA
08/2022
1Interleukin-22 (IL-22)IBA
08/2022
1Interleukin-17 (Interleukin 17)IBA
08/2022
1AcetyltransferasesIBA
07/2022
1IodineIBA
03/2022
1hexamminecobalt(III) tricarbonatocobaltate(III)IBA
03/2022
1Botulinum Toxins (Botulinum Toxin)IBA
01/2022
1hyaluronan-mediated motility receptorIBA
01/2022
1Arginine (L-Arginine)FDA Link
01/2022
1RNA Splicing FactorsIBA
01/2022

Therapy/Procedure

12Thyroidectomy
11/2022 - 11/2018
8Therapeutics
11/2021 - 11/2014
5Photochemotherapy (Photodynamic Therapy)
06/2022 - 09/2019
5Immunotherapy
06/2022 - 05/2014
4Drug Therapy (Chemotherapy)
06/2022 - 01/2018
3Radiotherapy
06/2022 - 01/2018
2Lasers (Laser)
06/2022 - 09/2019
2Neck Dissection (Radical Neck Dissection)
01/2020 - 09/2005
1Surgical Amputation (Amputations)
06/2022
1Debridement
06/2022